CLINICAL_TRIALS
trial_result
· 2017-03-23
Clinical Trial Update: Open Label Study of GSK2402968 in Subjects With Duchenne Muscular Dystrophy [Phase 3]
Summary
Open-label Phase 3 trial of GSK2402968 for Duchenne muscular dystrophy has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Muscular Dystrophies | Phase 3 | Status: TERMINATED